Quarterly report pursuant to Section 13 or 15(d)

Note 14 - Fair Value (Details Textual)

v3.20.2
Note 14 - Fair Value (Details Textual) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2020
Sep. 30, 2020
Dec. 31, 2019
Other than Temporary Impairment, Credit Losses Recognized in Earnings, Additions, Additional Credit Losses $ 0    
Available-for-sale Securities, Amortized Cost Basis, Total   $ 2,200  
Impaired Financing Receivable, Recorded Investment, Total   12,300 $ 7,200
Impaired Financing Receivable, Related Allowance   1,300 166
Impaired Financing Receivable, Fair Value   $ 11,000 $ 7,100